MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2

被引:52
作者
Huang, Xiaori [1 ]
Wang, Lei [1 ]
Liu, Wei [1 ]
Li, Fei [1 ]
机构
[1] Peoples Hosp Rizhao, Dept Resp Med, 126 Taian Rd, Rizhao 276826, Shandong, Peoples R China
关键词
miR-497-5p; proliferation; invasion; FGF2; non-small cell lung cancer; GROWTH-FACTOR; 2; TUMOR-GROWTH; METASTASIS; MIR-497; OSTEOSARCOMA; BIOMARKER; THERAPY; YAP1;
D O I
10.3892/ol.2019.9954
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Increasing number of microRNAs (miRNAs) have been reported to play an important role in the development and progression of non-small cell lung cancer (NSCLC). In particular, microRNA-497-5p (miR-497-5p) has been proposed as a tumor suppressor miRNA in human cancers. However, the role of miR-497-5p and its potential molecular mechanism associated with NSCLC are less studied. Therefore, the role of miR-497-5p in the pathogenesis of NSCLC was investigated. In the present study, the expression of miR-497-5p was significantly downregulated in NSCLC. Moreover, overexpression of miR-497-5p inhibited the proliferation and invasion of NSCLC cells by suppressing FGF2. In addition, FGF2 was a downstream target of miR-497-5p in NSCLC. FGF2 was upregulated in NSCLC promoting cell proliferation and invasion. Overexpression of FGF2 impaired the inhibitory effect of miR-497-5p in NSCLC. Taken together, these results demonstrate that miR-497-5p is a tumor suppressor miRNA and demonstrate its potential for future use in the treatment of human NSCLC.
引用
收藏
页码:3425 / 3431
页数:7
相关论文
共 36 条
[1]  
[Anonymous], ONCOTARGET
[2]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[3]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[4]   MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2 [J].
Cheng, Zhenshun ;
Ma, Rongli ;
Tan, Weijun ;
Zhang, Li .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2014, 46
[5]   Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion [J].
Coleman, Stacey J. ;
Chioni, Athina-Myrto ;
Ghallab, Mohammed ;
Anderson, Rhys K. ;
Lemoine, Nicholas R. ;
Kocher, Hemant M. ;
Grose, Richard P. .
EMBO MOLECULAR MEDICINE, 2014, 6 (04) :467-481
[6]  
Del Vescovo V, 2014, WORLD J CLIN ONCOL, V5, P604, DOI 10.5306/wjco.v5.i4.604
[7]  
FERGUSON MK, 1990, HEMATOL ONCOL CLIN N, V4, P1053
[8]   miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways [J].
He, Qingmei ;
Ren, Xianyue ;
Chen, Jiewei ;
Li, Yingqin ;
Tang, Xinran ;
Wen, Xin ;
Yang, Xiaojing ;
Zhang, Jian ;
Wang, Yaqin ;
Ma, Jun ;
Liu, Na .
ONCOTARGET, 2016, 7 (03) :3047-3058
[9]  
Hu J, 2016, AM J TRANSL RES, V8, P3023
[10]   miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer [J].
Hu, Y. ;
Qiu, Y. ;
Yague, E. ;
Ji, W. ;
Liu, J. ;
Zhang, J. .
CELL DEATH & DISEASE, 2016, 7 :e2291-e2291